WallStreetZenWallStreetZen
Analyst Ranking
Bottom 3%
#4429 out of 4563 analysts
Average Return
-13.28%
Win Rate
29%24 out of 82
Risk vs Reward
Poor
Good

David Turkaly's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Icad IncICAD
+99.77%$8.88$17.74
2020-02-04 -
2021-02-05
Buy
Si Bone IncSIBN
+34.91%$12.69$17.12
2022-11-07 -
2023-11-07
Buy
Steris PLCSTE
+34.16%$114.74$153.94
2018-08-08 -
2019-08-09
Buy
Haemonetics CorpHAE
+34.12%$61.51$82.50
2021-11-09 -
2022-11-09
Buy
Neuronetics IncSTIM
+33.45%$2.81$3.75
2023-05-09 -
2024-04-24
Buy

David Turkaly Analyst Color

Get additional color on David Turkaly's coverage of popular stocks

David Turkaly's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Tela Bio IncTELA
4Buy$15.00+237.08%Reiterates
a month ago
Orthopediatrics CorpKIDS
7Buy$50.00+60.26%Reiterates
2 months ago
Integra Lifesciences Holdings CorpIART
9Buy$49.00+66.78%Maintains
2 months ago
Teleflex IncTFX
10Buy$285.00+34.96%Reiterates
2 months ago
Lantheus Holdings IncLNTH
5Buy$100.00+53.35%Reiterates
2 months ago
Steris PLCSTE
9Buy$265.00+30.67%Reiterates
3 months ago
Zimmer Biomet Holdings IncZBH
10Buy$140.00+15.54%Maintains
5 months ago
Nevro CorpNVRO
5Buy$40.00+219.74%Maintains
9 months ago
Haemonetics CorpHAE
5Buy$115.00+33.38%Maintains
a year ago
Neuronetics IncSTIM
3Buy$12.00+220.00%Reiterates
a year ago
Axogen IncAXGN
3Buy$20.00+191.12%Reiterates
a year ago
Paragon 28 IncFNA
3Buy$30.00+211.20%Reiterates
a year ago
Si Bone IncSIBN
4Buy$32.00+112.20%Reiterates
a year ago
Icad IncICAD
4Buy$4.00N/AMaintains
a year ago
Apyx Medical CorpAPYX
1Buy$14.00N/AMaintains
3 years ago
Cognyte Software LtdCGNT
1Buy$5.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.